1. Home
  2. FVCB vs GALT Comparison

FVCB vs GALT Comparison

Compare FVCB & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FVCBankcorp Inc.

FVCB

FVCBankcorp Inc.

HOLD

Current Price

$14.46

Market Cap

229.7M

Sector

Finance

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$3.06

Market Cap

203.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FVCB
GALT
Founded
2007
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
229.7M
203.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FVCB
GALT
Price
$14.46
$3.06
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$16.00
$8.50
AVG Volume (30 Days)
32.6K
701.8K
Earning Date
01-23-2026
11-14-2025
Dividend Yield
1.68%
N/A
EPS Growth
328.55
N/A
EPS
1.17
N/A
Revenue
$64,242,000.00
N/A
Revenue This Year
$14.18
N/A
Revenue Next Year
$8.33
N/A
P/E Ratio
$12.24
N/A
Revenue Growth
41.04
N/A
52 Week Low
$9.49
$1.11
52 Week High
$14.50
$7.13

Technical Indicators

Market Signals
Indicator
FVCB
GALT
Relative Strength Index (RSI) 70.39 29.28
Support Level $13.87 $2.90
Resistance Level $14.31 $3.27
Average True Range (ATR) 0.32 0.27
MACD 0.01 -0.04
Stochastic Oscillator 84.89 9.66

Price Performance

Historical Comparison
FVCB
GALT

About FVCB FVCBankcorp Inc.

FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: